Summary

Global C-reactive protein (CRP) testing market was valued at USD 1,680.20 million in 2024 and is expected to witness steady growth, with a projected compound annual growth rate (CAGR) of 2.10% through 2030. CRP testing is a widely utilized laboratory diagnostic tool that measures the concentration of C-reactive protein—a liver-produced biomarker indicative of inflammation—in the blood. This test is instrumental in evaluating the body's inflammatory response to infections, injuries, and chronic conditions.
Healthcare professionals frequently use CRP testing to diagnose and monitor a broad range of conditions, including infectious diseases, autoimmune disorders, cardiovascular ailments, and post-surgical complications. Test results, reported in milligrams per liter (mg/L), provide valuable insight into the severity and progression of inflammation, supporting timely diagnosis and disease management strategies.
Key Market Drivers
Increasing Prevalence of Inflammatory and Infectious Diseases
A primary factor fueling market expansion is the growing global burden of inflammatory and infectious diseases. CRP testing is a critical diagnostic and prognostic tool used to detect and monitor a wide spectrum of conditions, including infections, autoimmune diseases, and cardiovascular disorders. As the incidence of these conditions rises globally, the demand for reliable inflammatory biomarkers like CRP continues to grow.
CRP testing is particularly important in managing chronic inflammatory diseases such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and lupus, as well as acute conditions like sepsis and pneumonia. It is estimated that 18 million individuals are affected by RA worldwide, with women comprising 70% of cases and over half of the affected population aged 55 or older. Notably, 13 million people suffer from moderate to severe RA, where early diagnosis and rehabilitation can significantly improve quality of life.
The rising prevalence of autoimmune and inflammatory conditions—driven by a combination of genetic, environmental, and lifestyle factors—has prompted broader adoption of CRP testing in routine clinical diagnostics.
Key Market Challenges
Lack of Specificity in Elevated CRP Levels
One of the key challenges limiting the market's full potential is the non-specific nature of elevated CRP levels. While CRP is a reliable marker of inflammation, it does not provide diagnostic specificity regarding the underlying cause. This ambiguity can complicate clinical decision-making, requiring additional tests to identify the root condition, thereby prolonging diagnosis and treatment initiation.
Furthermore, due to its generalized nature, CRP testing is sometimes ordered inappropriately or excessively, particularly in cases where inflammation may not be clinically significant. This can lead to unnecessary healthcare spending and inefficient utilization of resources, contributing to diagnostic overuse and potential overdiagnosis.
Key Market Trends
Growing Emphasis on Personalized Medicine
The increasing focus on personalized medicine represents a transformative trend shaping the CRP testing market. Personalized medicine seeks to tailor medical treatment based on individual patient profiles, including genetic characteristics, lifestyle, and biomarker data. CRP serves as a critical biomarker for inflammation, enabling healthcare providers to design more targeted and effective treatment plans.
CRP testing plays a pivotal role in risk assessment, particularly for cardiovascular diseases, where elevated CRP levels may signal higher risk and prompt preventive interventions tailored to an individual’s needs. It also supports continuous disease monitoring, allowing clinicians to track inflammation over time and make informed adjustments to treatment regimens based on changing CRP values.
Key Market Players
• Thermo Fisher Scientific, Inc.
• F. Hoffmann-La Roche Ltd.
• Danaher Corp
• Quest Diagnostics
• Siemens Healthineers AG
• Abbott Laboratories Inc.
• Merck KGaAA
• Zoetis Inc.
• Ortho Clinical Diagnostics
• Getein Biotech, Inc.

Report Scope:
In this report, the Global C-reactive Protein Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• C-reactive Protein Testing Market, By Assay Type:
o Immunoturbidimetric Assay
o ELISA
o Chemiluminescence Immunoassay
o Others
• C-reactive Protein Testing Market, By Detection Range:
o hs-CRP
o Conventional CRP
o cCRP
• C-reactive Protein Testing Market, By Disease Area:
o Cardiovascular Diseases
o Cancer
o Rheumatoid Arthritis
o Inflammatory Bowel Disease
o Endometriosis
o Lupus
o Others
• C-reactive Protein Testing Market, By End-User:
o Hospitals & Clinics
o Laboratories
o Assisted Living Healthcare Facilities
o Homecare
o Others
• C-reactive Protein Testing Market, By region:
o North America
§ United States
§ Canada
§ Mexico
o Asia-Pacific
§ China
§ India
§ South Korea
§ Australia
§ Japan
o Europe
§ Germany
§ France
§ United Kingdom
§ Spain
§ Italy
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global C-reactive Protein Testing Market.
Available Customizations:
Global C-reactive Protein Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).

ページTOPに戻る

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. C-reactive Protein Testing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Assay Type (Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others)
5.2.2. By Detection Range (hs-CRP, Conventional CRP, cCRP)
5.2.3. By Disease Area (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Others)
5.2.4. By End-Use Industry (Hospitals & Clinics, Laboratories, Assisted Living Healthcare Facilities, Homecare, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America C-reactive Protein Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Assay Type
6.2.2. By Detection Range
6.2.3. By Disease Are
6.2.4. By End-Use Industry
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States C-reactive Protein Testing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Assay Type
6.3.1.2.2. By Detection Range
6.3.1.2.3. By Disease Are
6.3.1.2.4. By End-Use Industry
6.3.2. Canada C-reactive Protein Testing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Assay Type
6.3.2.2.2. By Detection Range
6.3.2.2.3. By Disease Are
6.3.2.2.4. By End-Use Industry
6.3.3. Mexico C-reactive Protein Testing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Assay Type
6.3.3.2.2. By Detection Range
6.3.3.2.3. By Disease Are
6.3.3.2.4. By End-Use Industry
7. Europe C-reactive Protein Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Assay Type
7.2.2. By Detection Range
7.2.3. By Disease Are
7.2.4. By End-Use Industry
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany C-reactive Protein Testing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Assay Type
7.3.1.2.2. By Detection Range
7.3.1.2.3. By Disease Are
7.3.1.2.4. By End-Use Industry
7.3.2. United Kingdom C-reactive Protein Testing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Assay Type
7.3.2.2.2. By Detection Range
7.3.2.2.3. By Disease Are
7.3.2.2.4. By End-Use Industry
7.3.3. Italy C-reactive Protein Testing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Assay Type
7.3.3.2.2. By Detection Range
7.3.3.2.3. By Disease Are
7.3.3.2.4. By End-Use Industry
7.3.4. France C-reactive Protein Testing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Assay Type
7.3.4.2.2. By Detection Range
7.3.4.2.3. By Disease Are
7.3.4.2.4. By End-Use Industry
7.3.5. Spain C-reactive Protein Testing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Assay Type
7.3.5.2.2. By Detection Range
7.3.5.2.3. By Disease Are
7.3.5.2.4. By End-Use Industry
8. Asia-Pacific C-reactive Protein Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Assay Type
8.2.2. By Detection Range
8.2.3. By Disease Are
8.2.4. By End-Use Industry
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China C-reactive Protein Testing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Assay Type
8.3.1.2.2. By Detection Range
8.3.1.2.3. By Disease Are
8.3.1.2.4. By End-Use Industry
8.3.2. India C-reactive Protein Testing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Assay Type
8.3.2.2.2. By Detection Range
8.3.2.2.3. By Disease Are
8.3.2.2.4. By End-Use Industry
8.3.3. Japan C-reactive Protein Testing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Assay Type
8.3.3.2.2. By Detection Range
8.3.3.2.3. By Disease Are
8.3.3.2.4. By End-Use Industry
8.3.4. South Korea C-reactive Protein Testing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Assay Type
8.3.4.2.2. By Detection Range
8.3.4.2.3. By Disease Are
8.3.4.2.4. By End-Use Industry
8.3.5. Australia C-reactive Protein Testing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Assay Type
8.3.5.2.2. By Detection Range
8.3.5.2.3. By Disease Are
8.3.5.2.4. By End-Use Industry
9. South America C-reactive Protein Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Assay Type
9.2.2. By Detection Range
9.2.3. By Disease Are
9.2.4. By End-Use Industry
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil C-reactive Protein Testing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Assay Type
9.3.1.2.2. By Detection Range
9.3.1.2.3. By Disease Are
9.3.1.2.4. By End-Use Industry
9.3.2. Argentina C-reactive Protein Testing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Assay Type
9.3.2.2.2. By Detection Range
9.3.2.2.3. By Disease Are
9.3.2.2.4. By End-Use Industry
9.3.3. Colombia C-reactive Protein Testing Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Assay Type
9.3.3.2.2. By Detection Range
9.3.3.2.3. By Disease Are
9.3.3.2.4. By End-Use Industry
10. Middle East and Africa C-reactive Protein Testing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Assay Type
10.2.2. By Detection Range
10.2.3. By Disease Are
10.2.4. By End-Use Industry
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa C-reactive Protein Testing Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Assay Type
10.3.1.2.2. By Detection Range
10.3.1.2.3. By Disease Are
10.3.1.2.4. By End-Use Industry
10.3.2. Saudi Arabia C-reactive Protein Testing Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Assay Type
10.3.2.2.2. By Detection Range
10.3.2.2.3. By Disease Are
10.3.2.2.4. By End-Use Industry
10.3.3. UAE C-reactive Protein Testing Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Assay Type
10.3.3.2.2. By Detection Range
10.3.3.2.3. By Disease Are
10.3.3.2.4. By End-Use Industry
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions
13. Global C-reactive Protein Testing Market: SWOT Analysis
14. Competitive Landscape
14.1. Thermo Fisher Scientific, Inc.
14.1.1. Business Overview
14.1.2. Product & Service Offerings
14.1.3. Recent Developments
14.1.4. Financials (If Listed)
14.1.5. Key Personnel
14.1.6. SWOT Analysis
14.2. F. Hoffmann-La Roche Ltd.
14.3. Danaher Corp
14.4. Quest Diagnostics
14.5. Siemens Healthineers AG
14.6. Abbott Laboratories Inc.
14.7. Merck KGaAA
14.8. Zoetis Inc.
14.9. Ortho Clinical Diagnostics
14.10.Getein Biotech, Inc.
15. Strategic Recommendations
16. About Us & Disclaimer